<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Details for gene set MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP[GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/icon_16x16.png' rel='shortcut icon'></head><body><div class='keyValTable'><table cols='2' border='0'><th class='keyValTable'></th><th class='keyValTable'></th><tr><td>Dataset</td><td>normalized_raw_gene_counts_filtered_collapsed_to_symbols.phenotype.cls<br>#KRAS_G12D_versus_KRAS_WT.phenotype.cls<br>#KRAS_G12D_versus_KRAS_WT_repos</td></tr><tr><td>Phenotype</td><td>phenotype.cls#KRAS_G12D_versus_KRAS_WT_repos</td></tr><tr><td>Upregulated in class</td><td>1</td></tr><tr><td>GeneSet</td><td>MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP</td></tr><tr><td>Enrichment Score (ES)</td><td>0.64580333</td></tr><tr><td>Normalized Enrichment Score (NES)</td><td>1.8528765</td></tr><tr><td>Nominal p-value</td><td>0.0</td></tr><tr><td>FDR q-value</td><td>0.012797129</td></tr><tr><td>FWER p-Value</td><td>0.654</td></tr><caption class='table'>Table: GSEA Results Summary</caption></table></div><br><div class='image'><img name='enplot_MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP' src='enplot_MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP_544.png'><br><br><caption>Fig 1: Enrichment plot: MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP &nbsp&nbsp <br> Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List</caption></div><br><div class='richTable'><table cols='9' border='1'><th class='richTable'></th><th class='richTable'>PROBE</th><th class='richTable'>DESCRIPTION<br>(from dataset)</th><th class='richTable'>GENE SYMBOL</th><th class='richTable'>GENE_TITLE</th><th class='richTable'>RANK IN GENE LIST</th><th class='richTable'>RANK METRIC SCORE</th><th class='richTable'>RUNNING ES</th><th class='richTable'>CORE ENRICHMENT</th><tr><td class='lessen'>1</td><td><a href='https://ensembl.org/Search/Results?q=FXYD3'>FXYD3</a></td><td>FXYD domain containing ion transport regulator 3 [Source:HGNC Symbol;Acc:HGNC:4027]</td><td></td><td></td><td>243</td><td>0.646</td><td>0.1284</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>2</td><td><a href='https://ensembl.org/Search/Results?q=CTSK'>CTSK</a></td><td>cathepsin K [Source:HGNC Symbol;Acc:HGNC:2536]</td><td></td><td></td><td>430</td><td>0.536</td><td>0.2364</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>3</td><td><a href='https://ensembl.org/Search/Results?q=COL6A1'>COL6A1</a></td><td>collagen type VI alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2211]</td><td></td><td></td><td>723</td><td>0.442</td><td>0.3123</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>4</td><td><a href='https://ensembl.org/Search/Results?q=HBA2'>HBA2</a></td><td>hemoglobin subunit alpha 2 [Source:HGNC Symbol;Acc:HGNC:4824]</td><td></td><td></td><td>837</td><td>0.415</td><td>0.3990</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>5</td><td><a href='https://ensembl.org/Search/Results?q=COL6A2'>COL6A2</a></td><td>collagen type VI alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2212]</td><td></td><td></td><td>846</td><td>0.413</td><td>0.4952</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>6</td><td><a href='https://ensembl.org/Search/Results?q=PDGFA'>PDGFA</a></td><td>platelet derived growth factor subunit A [Source:HGNC Symbol;Acc:HGNC:8799]</td><td></td><td></td><td>1092</td><td>0.368</td><td>0.5582</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>7</td><td><a href='https://ensembl.org/Search/Results?q=CA12'>CA12</a></td><td>carbonic anhydrase 12 [Source:HGNC Symbol;Acc:HGNC:1371]</td><td></td><td></td><td>1169</td><td>0.355</td><td>0.6343</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>8</td><td><a href='https://ensembl.org/Search/Results?q=THY1'>THY1</a></td><td>Thy-1 cell surface antigen [Source:HGNC Symbol;Acc:HGNC:11801]</td><td></td><td></td><td>1729</td><td>0.276</td><td>0.6458</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>9</td><td><a href='https://ensembl.org/Search/Results?q=FOS'>FOS</a></td><td>Fos proto-oncogene, AP-1 transcription factor subunit [Source:HGNC Symbol;Acc:HGNC:3796]</td><td></td><td></td><td>2881</td><td>0.165</td><td>0.5746</td><td>No</td></tr><tr><td class='lessen'>10</td><td><a href='https://ensembl.org/Search/Results?q=PDGFRB'>PDGFRB</a></td><td>platelet derived growth factor receptor beta [Source:HGNC Symbol;Acc:HGNC:8804]</td><td></td><td></td><td>3245</td><td>0.135</td><td>0.5715</td><td>No</td></tr><tr><td class='lessen'>11</td><td><a href='https://ensembl.org/Search/Results?q=KRT17'>KRT17</a></td><td>keratin 17 [Source:HGNC Symbol;Acc:HGNC:6427]</td><td></td><td></td><td>4182</td><td>0.066</td><td>0.4976</td><td>No</td></tr><tr><td class='lessen'>12</td><td><a href='https://ensembl.org/Search/Results?q=TNC'>TNC</a></td><td>tenascin C [Source:HGNC Symbol;Acc:HGNC:5318]</td><td></td><td></td><td>4224</td><td>0.063</td><td>0.5085</td><td>No</td></tr><tr><td class='lessen'>13</td><td><a href='https://ensembl.org/Search/Results?q=GEM'>GEM</a></td><td>GTP binding protein overexpressed in skeletal muscle [Source:HGNC Symbol;Acc:HGNC:4234]</td><td></td><td></td><td>4627</td><td>0.036</td><td>0.4785</td><td>No</td></tr><tr><td class='lessen'>14</td><td><a href='https://ensembl.org/Search/Results?q=MMP9'>MMP9</a></td><td>matrix metallopeptidase 9 [Source:HGNC Symbol;Acc:HGNC:7176]</td><td></td><td></td><td>5105</td><td>0.005</td><td>0.4342</td><td>No</td></tr><tr><td class='lessen'>15</td><td><a href='https://ensembl.org/Search/Results?q=PLAU'>PLAU</a></td><td>plasminogen activator, urokinase [Source:HGNC Symbol;Acc:HGNC:9052]</td><td></td><td></td><td>5306</td><td>-0.008</td><td>0.4169</td><td>No</td></tr><tr><td class='lessen'>16</td><td><a href='https://ensembl.org/Search/Results?q=CCL2'>CCL2</a></td><td>C-C motif chemokine ligand 2 [Source:HGNC Symbol;Acc:HGNC:10618]</td><td></td><td></td><td>6445</td><td>-0.081</td><td>0.3272</td><td>No</td></tr><tr><td class='lessen'>17</td><td><a href='https://ensembl.org/Search/Results?q=SESN2'>SESN2</a></td><td>sestrin 2 [Source:HGNC Symbol;Acc:HGNC:20746]</td><td></td><td></td><td>6466</td><td>-0.082</td><td>0.3446</td><td>No</td></tr><tr><td class='lessen'>18</td><td><a href='https://ensembl.org/Search/Results?q=EGR1'>EGR1</a></td><td>early growth response 1 [Source:HGNC Symbol;Acc:HGNC:3238]</td><td></td><td></td><td>7636</td><td>-0.169</td><td>0.2725</td><td>No</td></tr><caption class='table'>Table: GSEA details&nbsp<a href='MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP.xls'>[plain text format]</a></caption></table></div><br><div class='image'><img name='MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP' src='MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP_545.png'><br><br><caption>Fig 2: MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP &nbsp&nbsp <br> Blue-Pink O' Gram in the Space of the Analyzed GeneSet</caption></div><br><div class='image'><img name='gset_rnd_es_dist' src='gset_rnd_es_dist_546.png'><br><br><caption>Fig 3: MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP: Random ES distribution &nbsp&nbsp <br> Gene set null distribution of ES for <b>MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP</b></caption></div><br></body></html>